HIGHLIGHTS ICHOM seeks to help standardize and align outcome measurement efforts globally.
C ardiovascular diseases are responsible for a significant burden on patients and health care systems worldwide (1, 2) . Although prevalence estimates in the developing world are largely lacking, heart failure affects up to 2% of the adult population in the developed world, with current estimates over the period of 2002 to 2014 suggesting an absolute increase in heart failure incidence and prevalence (3) (4) (5) . Estimates of the annual costs of heart failure treatment in the Unites States alone exceed $30 billion, over one-half of which is due to hospitalization (6) . It is therefore fundamental to be able to effectively monitor and manage this disease process.
Major guidelines exist for heart failure management, recommending therapies that affect the course of the disease. However, these guidelines most commonly focus on mortality, hospitalization, or surrogate measures such as change in ejection fraction or ventricular remodeling (6) (7) (8) . Though reducing symptoms and increasing functional capacity and quality of life are commonly articulated goals, there is less consensus on how best to achieve these outcomes. Additionally, the many international studies and registries that exist exhibit marked heterogeneity in terms of what is measured and the definitions thereof and tend to neglect patient-reported outcomes (9) . This has the effect of limiting Regulators and payers were not involved, as these would necessarily vary across countries and health care systems. As the focus of the set was its clinical applicability, emphasis was placed on patients and Following each teleconference, detailed minutes were circulated along with a survey including each specific discussion point. A two-thirds threshold was required to adopt a decision, which would be formally ratified at the subsequent teleconference. If twothirds was not reached, further discussion was undertaken at the start of the following teleconference with a second survey on these topics circulated, with a majority decision adopted if two-thirds was still not achieved.
Burns et al. Patients with a first presentation as cardiogenic shock were excluded from the scope, as there is often Table S1 ). Treatment variables will be captured through the patient's medical record.
Ongoing treatment variable modifications will be overseen by the ICHOM steering committee in line with emerging evidence. OUTCOME SET. To inform the development of the outcome set and understand real world heart failure outcome measurement efforts, the project team compiled information sourced from 24 heart failure registries. Ultimately, 241 discrete publications were surveyed ( Table 1) . This phase documented outcome domains, definitions, and ascertainment methods.
Registries predominantly focused on acute hospitalizations. Only a single registry included validated PROM tools (10, 11) . Detailed registry and reference information can be found in the Online Appendix and Online Table S3 .
The final outcome set includes 17 outcomes, reflecting 4 domains: functional; psychosocial; burden of care; and survival (Central Illustration). Institutions implementing the outcome set will collect data from hospital, clinician, and patient medical records; patient self-report; and administrative sources.
All-cause mortality was chosen, as disease-specific mortality is more difficult to accurately capture and is less meaningful to the individual patient. Table S4 .
Which PROM tool to recommend was controversial.
For technical quality, all 3 tools score highly in terms of validity, reliability, and responsiveness. The Table S8 ). Hyperlipidemia was not included given inconsistent evidence and a lack of working group consensus. Left ventricular ejection fraction was included due to it being a common marker of cardiac function, distinguishing heart failure with preserved or reduced ejection fraction. Steps were also taken to align variable definitions between the heart failure set and the related ICHOM coronary artery disease standard set (24) .
guidelines (Online
In the selection of case-mix adjustment variables, socioeconomic variables are important factors to consider when assessing outcomes in heart failure patients (25) . Whereas there was general agreement that the inclusion of socioeconomic variables would be beneficial, the working group was unable to reach consensus regarding which specific measures to include or which parameter(s) would be ideal. Also of concern was how to reconcile socioeconomic variables across countries and regions, which may have and is unique in that patient focus groups and interviews actively informed the development of the outcome set. In addition, we rely heavily on PROM assessment tools to obtain validated, reproducible, and meaningful assessments of the many domains of health status, adding additional depth and consistency beyond unstructured patient self-report.
Finally, by specifying routine follow-up intervals for health status assessment, we hope to be able to capture multiple repeat measures and trends with respect to long-term outcomes.
Standardizing outcome measurement allows comparison across regions by enabling groups to "speak the same language" when comparing outcome mea- The final stage of this project is to promote implementation of the standard set. Major hurdles to be overcome include the following: 1) budgeting;
2) local or regional agreement of clinicians willing With cooperation and leadership from working group members, ICHOM has partnered with sites in Europe, the Americas, and Asia to pilot and benchmark the implementation of the standard set. From here we hope to build toward a more generalized adoption of the set. Over time, we hope to be able to identify gaps in treatment and improve quality of care worldwide. 
